Zhao, S., Wu, W., Jiang, H., Ma, L., Pan, C., Jin, C., . . . Wang, K. (2021). Selective Inhibitor of the c-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib? Frontiers Media S.A.
Cita Chicago Style (17a ed.)Zhao, Shankun, Weizhou Wu, Hao Jiang, Lei Ma, Chengyi Pan, Chong Jin, Jinggang Mo, Liezhi Wang, y Kunpeng Wang. Selective Inhibitor of the C-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib? Frontiers Media S.A, 2021.
Cita MLA (8a ed.)Zhao, Shankun, et al. Selective Inhibitor of the C-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib? Frontiers Media S.A, 2021.